HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Brachytherapy is a specialized form of cancer treatment that involves the strategic placement of radioactive sources directly within or near the tumor. This targeted approach allows for the delivery of high doses of radiation to the cancerous cells while minimizing exposure to surrounding healthy tissues.
The procedure begins with the insertion of tiny radioactive seeds or sources into or around the tumor site. These sources emit radiation, effectively damaging the DNA of the cancer cells and impeding their ability to divide and grow. Brachytherapy is particularly advantageous for treating certain types of cancer, such as prostate, cervical, breast, and skin cancer.
One key advantage of brachytherapy is its ability to deliver a concentrated dose of radiation to the tumor, which can enhance treatment effectiveness. Additionally, this method often results in fewer side effects compared to external beam radiation therapy, as the radiation is focused on the specific area of concern.
Brachytherapy can be used as a standalone treatment or in combination with other therapies, depending on the type and stage of cancer. The duration of the treatment varies, with some cases requiring only a short exposure, while others may involve longer-term implantation of radioactive sources.
Overall, brachytherapy stands as a valuable tool in the arsenal of cancer treatments, offering precision and efficacy in the battle against malignancies. As ongoing research and advancements continue to refine this therapeutic approach, brachytherapy remains a promising option for improving outcomes and enhancing the quality of life for cancer patients.
